|
Jan. 27, 2022 |
|
|
Mar. 31, 2026 |
|
|
jRCTs041210135 |
PDE5 inhibitor could improve human sperm motility: a randamized trial (PEOS study) |
|
The effect of PDE5 inhibitor on human sperm (PEOS study) |
Inoue Takahiro |
||
Mie University Hospital |
||
Edobashi 2-174, Tsu city, Mie prefecture |
||
+81-59-232-1111 |
||
tinoue28@med.mie-u.ac.jp |
||
Kato Manabu |
||
Mie University Hospital |
||
Edobashi 2-174, Tsu city, Mie prefecture |
||
+81-59-232-1111 |
||
katouuro@clin.medic.mie-u.ac.jp |
Recruiting |
Jan. 27, 2022 |
||
| May. 26, 2025 | ||
| 20 | ||
Interventional |
||
randomized controlled trial |
||
open(masking not used) |
||
no treatment control/standard of care control |
||
parallel assignment |
||
treatment purpose |
||
1) Patients complained infertility and diagnosed as oligospermia, asthenozoospermia. |
||
1) Patients who use nitric acid drug which is contraindications for concomitant use. |
||
| 20age 0month 0week old over | ||
| 50age 0month 0week old under | ||
Male |
||
oligospermia, Asthesospermia, sperm shape abnormality, white blood cells in sperm |
||
Oral administartion (Tadalafil 1 tablet after morning meal for 24 weeks) |
||
oligospermia, Asthesospermia, sperm shape abnormality, white blood cells in sperm |
||
PDE5 inhibitor, oral administration |
||
20% improvement of sperm findings (sperm concentration) on 12 weeks after oral administration |
||
20 % or 50% improvement of sperm findings (sperm concentration or volume) on 6, 24, or 48 weeks after oral administration, 20 % improvement of sperm findings (sperm |
||
| Mie UniversityHospital Clinical Research Review Board | |
| 2-174 Edobashi Tsu city,, Mie | |
+81-59-231-5045 |
|
| mie-crb@mo.medic.mie-u.ac.jp | |
| Approval | |
Nov. 22, 2021 |
No |
none |